At 2 PM Monday afternoon Daniel Ward released his article on seeking Alpha titled "Why Numerous Upside Scenarios Make Venaxis a Biotech to buy"
Daniel is indicated having 797 followers, enough to make a difference with biotech such as Venaxis.
Was it a Pump and Dump ?
You have to ask Daniel that question.
CT Scan alone is less accurate and is extremely dangerous to children, not to speak of costs.
CEO and staff screwed up when they tried to get the test to stand alone but finally, the new April 6 filling corrected this mistake.. Yes, they should have known better but too late to cry over spilled milk.
Gone are the $ 4-5 potential share price valuation but low to mid $ 2 totally possible.
The run up started not yesterday but Monday afternoon at $ 0.50
Still 10% higher. Not bad for 2 days considering that it was not news generated.
Unfortunately, yes, This time is looks like it. Pump & Dump.
Too bad but when you look at it closely and review Steve recent comments, yes, it is really too soon for anything new, good or bad for that matter.
Not to forget that APPY 1 works and just needs fine tuning.
APPY 2 progressing. Euro looking promising and $ 22 M cash on hand with only $ 0.5 monthly burn.
Yes, still long road to full recovery but looking good for $ 1.50 ish just with good word from FDA and this will be well within 90 days from today. For sure will be event driven and what else can be much worse than current status ?
On the other hand, do not rush too too much to cover right now, when no news.
For longs, Short squeeze are always such fun to watch pannic buying.
Past few weeks have been tough for APPY shareholders but at $ 0.45 ish share price, it is a good bet considering $ 22 M cash on hand, Europe ramp up and FDA potential assistance to make it happen in US.
The one who knows is AS and his newly grant for each 1M shares at $ 6, 8, 10 1nd 12 to show it.
Plus off course, the 10+ M shares that he already owns.
At today's below $ 4 share price, it looks cheap.
Betting that AS will be a very rich man in a not too distant future.
ALL ON BOARD ???
OK, Maybe not all this year but first half looking good for AS
1 M at $6
1 M at $8
the $10 and $12 million shares may have to wait for 2016 but it does not seem that AS is going away soon.
OK, you may have a point. Personally I got real ticked off when management not only granted itself bonuses for doing their jobs but cashed them last month, even after having the FDA turned APPY 1 down.
However, what can be done about it ? It is what it is and at this stage, we better hope that they start to get it right on their own because unless someone buy the company, there will be no change.
Agreed with "seems good" which explains the lack of any leak prior the CC.
Pleased to hear that fresh modified APPY 1 filling with FDA was done yesterday ( that is very good )
but would prefer seeing current cash on hand strickly dedicated to APPY 1 and 2 instead of talking new business acquisition.
Europe is pot potting along just as expected. again one of those "seems good" with progress mentioned but not quantized, which would have been better.
At the end, yes, future still looks promising but nothing earth shattering right now.
In your view, Do you believe APPY 1 and 2 are good, working tests but just going through the process with wrong management or the entire APPY concept is faulty ?
It would not be too too surprising to have Alere closely listen to Steve comments. Steve has one more shoot at doing it right and today is a major moment for him as Venaxis CEO.
Selling Venaxis at this time, without a clear path to APPY 1 approval, would not be just a disaster for Steve but to all current shareholders. Go Steve, make it happen, you are almost there.
It is all about how good was the discussion and guidance by the FDA.
It is not about does APPY 1 works or not, it is to be sure that ER can read test results properly each and every time.
This time around, FDA will make sure that Venaxis frames study results properly.
No one wants over exposing children to CT scans when there is safer and less expensive alternative.
Come on, not even a tinny leak ?
Looking for huge spike with good news.
Bad news or no new information are already priced in as status quo is already as bad as it can be.
"now" is tomorrow at 4.30 PM.
Excellent, should be very interesting.
Could it be that last Thursday mid day jump had something to do with tomorrow ?
Plus Venaxis has D&O insurance as well for added protection. (just in case something comes up later on) No hurdle here but now, time to deal with FDA comments and Europe sales/progress.
Over 2 months since nasty FDA APPY 1 surprise, it well about right to go forward full speed a head resuming US approval process.